Dr. Reddy’s launches Nexret™
Dr. Reddy’s Laboratories Ltd. has launched Nexret™ (Tretinoin 0.04% & 0.1% as microspheres) in India. It marks the entry of Dr. Reddy’s into the topical anti-acne segment, a commonly diagnosed condition by dermatologists. Nexret™ is an anti-acne formulation made from a proprietary non-porous microsphere technology. This unique technology minimises irritation associated with drugs like Tretinoin and provides controlled delivery of drug to the skin. Nexret™ is available in gel formulation and in pack size of 15 gm. The anti-acne market in India is about Rs 130 crores growing at the rate of about 14%.
Topical Tretinoin is considered as one of the most efficacious drug to treat Acne. However, its use is restricted because of irritation, erythema, burning, dryness, etc. Nexret™ contains Tretinoin entrapped in microspheres enabling more amount of drug loading and also reducing unwanted adverse effects. This microsphere technology has been developed internally and patent application has been filed in seven countries.
Source: Dr Reddy’s Labs